reserpine has been researched along with doxapram in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kuga, T; Naito, J | 1 |
| Kubota, T; Nakazawa, M; Sasaki, T | 1 |
1 review(s) available for reserpine and doxapram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for reserpine and doxapram
| Article | Year |
|---|---|
[Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrolinone hydrochloride (doxapram). 1. The action on the central nervous system].
Topics: Amides; Animals; Atropine; Blood Pressure; Central Nervous System; Central Nervous System Stimulants; Dogs; Doxapram; Electrocardiography; Ethylenediamines; Hexamethonium Compounds; Male; Mice; Morpholines; Pentobarbital; Phentolamine; Rabbits; Rats; Reserpine; Respiration; Seizures; Sympathetic Nervous System; Vagotomy | 1973 |
[Effect of 1-ethyl-4-(2-morpholinoethyl)-3, 3-diphenyl-2-pyrrolidinone hydrochloride hydrate (doxapram) on respiration and circulation].
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Cocaine; Cordotomy; Dogs; Doxapram; Drug Synergism; Female; Femoral Artery; Guanethidine; Heart Rate; Hemodynamics; Morpholines; Nicotine; Norepinephrine; Oxygen; Phenoxybenzamine; Regional Blood Flow; Reserpine; Respiration; Tyramine | 1974 |